-transparent.png){kind=logo}
Activity levels of N-acetyltransferase and acetylation types in patients with malignant lymphomas, following sulfadimidine loading, were established. The ratio of "fast" and "slow" acetylators among patients with malignant lymphomas is shown to be similar to that in control group. The rate of acetylation in "slow"-acetylating patients, however, was higher than in healthy controls. A relationship of N-acetyltransferase activity, tumor progression and, to a considerable extent, effectiveness of therapy was shown.
Related Publications
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
May 1978,
Vnitrni lekarstvi,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
January 1987,
Haematologica,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
May 1999,
Drug metabolism reviews,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
January 1989,
Vutreshni bolesti,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
July 1996,
Leukemia & lymphoma,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
January 1997,
Digestion,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
April 1982,
Haematologica,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
March 1982,
Problemy gematologii i perelivaniia krovi,
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
January 1985,
Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
Chekharina YeA, and
L N Bulovskaya, and
M V Pavlova, and
R G Krupkin
April 1985,
Klinicheskaia meditsina,
